Potential impact of a free online HIV treatment response prediction system for reducing virological failures and drug costs after antiretroviral therapy failure in a resource-limited setting
Andrew D Revell, Gerardo Alvarez-Uria, Dechao Wang, Anton Pozniak, Julio S Montaner, H Clifford Lane, Brendan A Larder, Andrew D Revell, Gerardo Alvarez-Uria, Dechao Wang, Anton Pozniak, Julio S Montaner, H Clifford Lane, Brendan A Larder
Abstract
Objective: Antiretroviral drug selection in resource-limited settings is often dictated by strict protocols as part of a public health strategy. The objective of this retrospective study was to examine if the HIV-TRePS online treatment prediction tool could help reduce treatment failure and drug costs in such settings.
Methods: The HIV-TRePS computational models were used to predict the probability of response to therapy for 206 cases of treatment change following failure in India. The models were used to identify alternative locally available 3-drug regimens, which were predicted to be effective. The costs of these regimens were compared to those actually used in the clinic.
Results: The models predicted the responses to treatment of the cases with an accuracy of 0.64. The models identified alternative drug regimens that were predicted to result in improved virological response and lower costs than those used in the clinic in 85% of the cases. The average annual cost saving was $364 USD per year (41%).
Conclusions: Computational models that do not require a genotype can predict and potentially avoid treatment failure and may reduce therapy costs. The use of such a system to guide therapeutic decision-making could confer health economic benefits in resource-limited settings.
References
- World Health Organisation. Antiretroviral Therapy for HIV Infection in Adolescents and Adults: Recommendations for a Public Health Approach—2010 Revision. Geneva, Switzerland: WHO; 2010.
- DART Trial Team. Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial. The Lancet. 2010;375(9709):123–131.
- Hosseinipour MC, van Oosterhout JJG, Weigel R, et al. The public health approach to identify antiretroviral therapy failure: high-level nucleoside reverse transcriptase inhibitor resistance among Malawians failing first-line antiretroviral therapy. AIDS. 2009;23(9):1127–1134.
- Sigaloff KCE, Hamers RL, Wallis CL, et al. Unnecessary antiretroviral treatment switches and accumulation of HIV resistance mutations; two arguments for viral load monitoring in Africa. Journal of Acquired Immune Deficiency Syndromes. 2011;58(1):23–31.
- Zhou J, Li PCK, Kumarasamy N, et al. Deferred modification of antiretroviral regimen following documented treatment failure in Asia: results from the TREAT Asia HIV Observational Database (TAHOD) HIV Medicine. 2010;11(1):31–39.
- Keiser O, Chi BH, Gsponer T, et al. Outcomes of antiretroviral treatment in programmes with and without routine viral load monitoring in southern Africa. AIDS. 2011;25(14):1761–1769.
- Barth RE, Aitken SC, Tempelman H, et al. Accumulation of drug resistance and loss of therapeutic options precede commonly used criteria for treatment failure in HIV-1 subtype-C-infected patients. Antiviral Therapy. 2012;17(2):377–386.
- Thompson MA, Aberg JA, Hoy JF, et al. Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society-USA panel. The Journal of the American Medical Association. 2012;308(4):387–402.
- Larder BA, DeGruttola V, Hammer S, et al. The international HIV resistance response database initiative: a new global collaborative approach to relating viral genotype treatment to clinical outcome. Antiviral Therapy. 2002;7, article S111
- Revell AD, Wang D, Boyd MA, et al. The development of an expert system to predict virological response to HIV therapy as part of an online treatment support tool. AIDS. 2011;25(15):1855–1863.
- Revell AD, Wang D, Wood R, et al. Computational models can predict response to HIV therapy without a genotype and may reduce treatment failure in different resource-limited settings. Journal of Antimicrobial Chemotherapy. 2013;68(6):1406–1414.
- Larder BA, Revell A, Mican JM, et al. Clinical evaluation of the potential utility of computational modeling as an HIV treatment selection tool by physicians with considerable HIV experience. AIDS Patient Care and STDs. 2011;25(1):29–36.
- Revell AD, Wang D, Harrigan R, et al. Modelling response to HIV therapy without a genotype: an argument for viral load monitoring in resource-limited settings. Journal of Antimicrobial Chemotherapy. 2010;65(4):605–607.dkq032
- Revell AD, Ene L, Duiculescu DA, et al. The use of computational models to predict response to HIV therapy for clinical cases in Romania. Germs. 2012;2(1):6–11.
- Revell AD, Wang D, Harrigan R, et al. Computational models developed without a genotype for resource-poor countries predict response to HIV treatment with 82% accuracy. Antiviral Therapy. 2009;14(Supplement 1, article A38)
- Larder BA, Revell AD, Wang D, et al. Modelling response to antiretroviral therapy with a genotype as a clinical tool for resource-limited settings. Antiviral Therapy. 2011;16(Supplement 1, article A42)
- Revell AD, Wang D, Streinu-Cercel A, et al. Models that accurately predict response to HIV therapy are generalisable to unfamiliar datasets and settings. Antiviral Therapy. 2012;17(Supplement 1, article A145)
- Alvarez-Uria G, Midde M, Pakam R, Naik PK. Gender differences, routes of transmission, socio-demographic characteristics and prevalence of HIV related infections of adults and children in an HIV cohort from a rural district of India. Infectious Disease Reports. 2012;4, article e19
- Alvarez-Uria G, Midde M, Pakam R, Kannan S, Bachu L, Naik PK. Factors associated with late presentation of HIV and estimation of antiretroviral treatment need according to CD4 lymphocyte count in a resource-limited setting: data from an HIV cohort study in India. Interdisciplinary Perspectives on Infectious Diseases. 2012;2012:7 pages.293795
- Larder BA, Revell AD, Wang D, et al. Accurate prediction of response to HIV therapy without a genotype a potential tool for therapy optimisation in resource-limited settings. Antiviral Therapy. 2013;18(Supplement 1, article A20)
- World Health Organisation. Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection: Recommendations for a Public Health Approach. Geneva, Switzerland: WHO; 2013.
Source: PubMed